Das Pradhan, A., Glynn, R. J., Fruchart, J.-C., MacFadyen, J. G., Zaharris, E. S., Everett, B. M., Campbell, S. E., Oshima, R., Amarenco, P., Blom, D. J., Brinton, E. A., Eckel, R. H., Elam, M. B., Felicio, J. S., Ginsberg, H. N., Goudev, A., Ishibashi, S., Joseph, J., Kodama, T., … Ridker, P. M. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New England Journal of Medicine, 387(21), 1923–1934. https://doi.org/10.1056/nejmoa2210645
Subjects:
Cardiovascular Diseases
(MeSH)
Diabetes Mellitus, Type 2
(MeSH)
Hypertriglyceridemia
(MeSH)
Hypolipidemic Agents
(MeSH)
PPAR alpha
(MeSH)
Publication Type:
Article
Unique ID:
10.1056/nejmoa2210645
PMID:
Journal:
Publication Date:
Data Source:
PubMed